Chronic opioid therapy for non-cancer pain

British Journal of Anaesthesia

Volumn 87, Issue 1, 2001, Pages 133-143

  Collett, B J ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Analgesics opioid; Pain, chronic non cancer

Indexed keywords

BENZATROPINE; BUPIVACAINE; CODEINE; DIAZEPAM; LIDOCAINE; METHADONE; MORPHINE; OPIATE; OXYCODONE; PARACETAMOL; PLACEBO;

ALLODYNIA; ARTICLE; CANCER PAIN; CHRONIC PAIN; CLINICAL TRIAL; COGNITIVE DEFECT; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DISABILITY; DRUG DEPENDENCE; DRUG EFFICACY; DRUG TOLERANCE; HUMAN; HYPERALGESIA; INFORMED CONSENT; INSOMNIA; LONG TERM CARE; MEDICAL DOCUMENTATION; NAUSEA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RESPIRATION DEPRESSION; SEXUAL DYSFUNCTION; SOMNOLENCE; SUSTAINED RELEASE PREPARATION; TREATMENT PLANNING;

EID: 0034940234     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/87.1.133     Document Type: Article

References (102)

1. The Management of chronic pain in older persons
2. Efficacy of controlled-release codeine in chronic non-malignant pain: A randomized, placebo-controlled clinical trial
3. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain
4. Intraspinal narcotic analgesia in the treatment of chronic pain
5. Insights into the development of tolerance
6. Australian trends in opioid prescribing for non-cancer pain, 1986-1996
7. Chronic nonmalignant pain treated with long-term oral narcotic analgesics
8. Prevalence of chronic pain in the British population: A telephone survey of 1037 households
9. Opioids in nonmalignant pain: Questions in search of answers
10. Pain, opioid use, and survival in hospitalized patients with advanced cancer
11. The cognitive effects of the administration of narcotic analgesics in patients with cancer pain
12. Morphine-induced immunomodulation in mice: Temporal relationships
13. Medication management in patients with chronic non-malignant pain. A review of the use of a drug withdrawal protocol
14. Use of opioid analgesics for the treatment of chronic noncancer pain-A consensus statement and guidelines from the Canadian Pain Society
15. The relevance of opioids and opioid receptors on immunocompetence and immune homeostasis
16. Prescription opiate abuse in chronic pain patients: Clinical criteria, incidence, and predictors
17. Prolonged morphine self-administration and addiction liability. Evaluation of two theories in a bone marrow transplant unit
18. Opioids, chronic pain, and the law
19. Is disease progression the major factor in morphine 'tolerance' in cancer pain treatment?
20. Cold-pressor pain tolerance in opiate and cocaine abusers: Correlates of drug type and use status
21. Screening for addiction in patients with chronic pain and 'problematic' substance use: Evaluation of a pilot assessment tool
22. Prescribing opioids for chronic pain in non-malignant disease
23. Epidemiology of persistent pain
24. Cognitive impairment among methadone maintenance patients
25. Randomised double-blind active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain
26. The epidemiology of chronic pain in the community
27. Opioid modulation of immune responses: Effects on phagocyte and lymphoid cell populations
28. Opioids for chronic musculoskeletal pain
29. Narcotic addiction in patients with chronic pain
30. Chronic pain in the spinal cord injured: Statistical approach and pharmacological treatment
31. Substance dependence and chronic pain: Experience with treatment and follow-up results
32. Drug abuse, dependence, and addiction in chronic pain patients
33. Clinical tolerance to opioids
34. Long-term use of narcotic analgesics in chronic pain
35. A comparison of the effects of morphine sulphate and nitrous oxide analgesia on chronic pain states in man
36. Opioids in chronic non-malignant pain: A criteria-based review of the literature
37. The use of oral opioids in patients with chronic non-cancer pain
38. Outcome of chronic opioid therapy for non-cancer pain
39. A comparison of cognitive impairment due to benzodiazepines and to narcotics
40. Prevalence of abuse and dependency in chronic pain patients
41. The analgesic connection: The Nathan B. Eddy memorial lecture
42. Opioids in the treatment of neuropathic pain: A systematic review of controlled clinical trials
43. Drug addiction and drug abuse
44. Survey of opioid use in chronic nonmalignant pain patients
45. Comprehensive pretreatment and outcome assessment for chronic opioid therapy in nonmalignant pain
46. Opioid therapy for chronic noncancer back pain. A randomised prospective study
47. Controlled substances, medical practice, and the law
48. Codeine plus paracetamol versus paracetamol in longer-term treatment of chronic pain due to osteoarthritis of the hip. A randomised, double-blind, multi-centre study
49. Types and characteristics of drug addicts
50. Medical safety and side effects of methadone in tolerant individuals
51. Morphine differentially affects the sensory and affective pain ratings in neuropathic and idiopathic forms of pain
52. Cognitive performance, mood and experimental pain before and during morphine-induced analgesia in patients with chronic non-malignant pain
53. Prescription drug-induced organic brain syndrome
54. Local analgesia without anaesthesia using peripheral perineural morphine injections
55. Prescription medication dependence and neuropsychologic function
56. Acute opiate tolerance in man
57. Opioid sensitivity of chronic pain: A patient-controlled analgesia method
58. Opioids in chronic pain of non malignant origin: State of the debate in New Zealand
59. Randomised trial of oral morphine for chronic non-cancer pain
60. Comparison of the time course of morphine's analgesic and immunologic effects
61. Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients
62. Does prolonged oral treatment with sustained-release morphine tablets alter immune function?
63. Chronic intrathecal morphine for intractable pain
64. Management of pain during debridement: A survey of U.S. burn units
65. Opioids in ischaemic pain
66. Long-term spinal administration of morphine in cancer and non-cancer pain: A retrospective study
67. Chronic use of opioid analgesics in non-malignant pain: Report of 38 cases
68. Opioid therapy for chronic nonmalignant pain: A review of the critical issues
69. Tolerance to opioid analgesics: Clinical aspects
70. Addiction rare in patients treated with narcotics
71. Opiate reduction in chronic pain patients: A comparison of patient-controlled reduction and staff controlled cocktail methods
72. Experience in the management of patients medically addicted to narcotics
73. Opiates and infection
74. Opiates and immune function. Consequences on infectious diseases with special references for AIDS
75. Both intravenous lidocaine and morphine reduce the pain of post-herpetic neuralgia
76. The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients
77. Addiction in the treatment of pain: Significance, recognition and management
78. Long-term opioid therapy: Assessment of consequences and risks
79. Long-term use of opioid analgesics for the treatment of chronic pain of nonmalignant origin
80. A long-term survey of morphine in cancer pain patients
81. Opioid use in the treatment of chronic pain: Assessment of addiction
82. Opioid analgesics and the risk of hip fracture in the elderly: Codeine and propoxyphene
83. Transdermal fentanyl as treatment for chronic low back pain
84. Pain, sedation and reaction time during long-term treatment of cancer patients with oral and epidural opioids
85. Neuropsychological performance in cancer patients: The role of oral opioids, pain and performance status
86. Opioids for chronic pain of non-malignant origin-coercion or consent?
87. Epidemiology of pain requiring strong analgesics outside hospital in a geographically defined population in Denmark
88. Opioid analgesics in the treatment of chronic intractable pain of non-neoplastic origin
89. Chronic opioid treatment of intractable, non-malignant pain
90. Physicians' attitudes and practices regarding the long-term prescribing of opioids for non-cancer pain
91. What position do APS's physicians take on chronic opioid therapy?
92. What factors affect physicians' decisions to prescribe opioids for chronic noncancer pain patients?
93. Clinicians attitudes about prolonged use of opioids and the issue of patient heterogeneity
94. Clinical experience with diamorphone in advanced malignant disease
95. Long-term use of narcotic/antidepressant medication in the management of phantom limb pain
96. Driving ability in cancer patients receiving long-term morphine analgesia
97. A randomized trial in postherpetic neuralgia
98. Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers
99. Codeine and oxycodone use in patients with chronic rheumatic disease pain
100. A review of the effects of opioids on psychomotor and cognitive functioning in humans
101. Long-term oral opioid therapy in patients with chronic nonmalignant pain